Brodalumab: the first anti- IL-17 receptor agent for psoriasis

Puig, L

Puig, L (reprint author), Univ Autonoma Barcelona, Dept Dermatol, Hosp Santa Creu & St Pau, St Quinti 89, Barcelona 08041, Spain.

DRUGS OF TODAY, 2017; 53 (5): 283

Abstract

Psoriasis is a chronic immune-mediated inflammatory skin disease in which the alteration of the interleukin-23 (IL-23)/IL-17 cytokine axis appears to ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索